Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs PROCTER & GAMBLE HEALTH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DIVIS LABORATORIES PROCTER & GAMBLE HEALTH DIVIS LABORATORIES/
PROCTER & GAMBLE HEALTH
 
P/E (TTM) x 66.4 34.5 192.4% View Chart
P/BV x 7.2 10.5 68.3% View Chart
Dividend Yield % 0.9 2.0 43.0%  

Financials

 DIVIS LABORATORIES   PROCTER & GAMBLE HEALTH
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-23
PROCTER & GAMBLE HEALTH
Jun-23
DIVIS LABORATORIES/
PROCTER & GAMBLE HEALTH
5-Yr Chart
Click to enlarge
High Rs4,6415,366 86.5%   
Low Rs2,7303,883 70.3%   
Sales per share (Unadj.) Rs292.6740.7 39.5%  
Earnings per share (Unadj.) Rs68.7138.2 49.7%  
Cash flow per share (Unadj.) Rs81.6155.2 52.6%  
Dividends per share (Unadj.) Rs30.0095.00 31.6%  
Avg Dividend yield %0.82.1 39.6%  
Book value per share (Unadj.) Rs480.9447.6 107.4%  
Shares outstanding (eoy) m265.4716.60 1,599.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x12.66.2 201.8%   
Avg P/E ratio x53.733.5 160.4%  
P/CF ratio (eoy) x45.229.8 151.5%  
Price / Book Value ratio x7.710.3 74.2%  
Dividend payout %43.768.7 63.6%   
Avg Mkt Cap Rs m978,37876,761 1,274.6%   
No. of employees `000NANA-   
Total wages/salary Rs m9,7502,062 472.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m77,67512,296 631.7%  
Other income Rs m3,447184 1,874.2%   
Total revenues Rs m81,12212,480 650.0%   
Gross profit Rs m23,6913,247 729.7%  
Depreciation Rs m3,432281 1,221.3%   
Interest Rs m208 254.5%   
Profit before tax Rs m23,6863,142 753.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,453847 643.5%   
Profit after tax Rs m18,2342,295 794.6%  
Gross profit margin %30.526.4 115.5%  
Effective tax rate %23.027.0 85.4%   
Net profit margin %23.518.7 125.8%  
BALANCE SHEET DATA
Current assets Rs m97,43711,713 831.9%   
Current liabilities Rs m15,3316,791 225.8%   
Net working cap to sales %105.740.0 264.1%  
Current ratio x6.41.7 368.5%  
Inventory Days Days8263 3.2%  
Debtors Days Days842343 245.2%  
Net fixed assets Rs m51,12810,617 481.6%   
Share capital Rs m531166 319.8%   
"Free" reserves Rs m127,1407,265 1,750.2%   
Net worth Rs m127,6717,431 1,718.2%   
Long term debt Rs m00-   
Total assets Rs m148,56522,330 665.3%  
Interest coverage x1,209.5409.1 295.7%   
Debt to equity ratio x00-  
Sales to assets ratio x0.50.6 94.9%   
Return on assets %12.310.3 119.2%  
Return on equity %14.330.9 46.2%  
Return on capital %18.642.4 43.8%  
Exports to sales %85.70-   
Imports to sales %19.813.1 151.6%   
Exports (fob) Rs m66,537NA-   
Imports (cif) Rs m15,3781,605 957.9%   
Fx inflow Rs m66,5371,465 4,541.1%   
Fx outflow Rs m15,7151,605 978.9%   
Net fx Rs m50,822-140 -36,249.7%   
CASH FLOW
From Operations Rs m24,5972,360 1,042.3%  
From Investments Rs m-27,076-215 12,593.6%  
From Financial Activity Rs m-7,972-985 809.6%  
Net Cashflow Rs m-10,4511,160 -900.7%  

Share Holding

Indian Promoters % 51.9 0.0 -  
Foreign collaborators % 0.0 51.8 -  
Indian inst/Mut Fund % 36.7 20.3 181.3%  
FIIs % 14.9 7.6 195.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.1 48.2 99.8%  
Shareholders   354,482 56,730 624.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DIVIS LABORATORIES With:   SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on Divis Laboratories vs Procter & Gamble Health

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Divis Laboratories vs Procter & Gamble Health Share Price Performance

Period Divis Laboratories Procter & Gamble Health S&P BSE HEALTHCARE
1-Day 2.82% -0.43% 1.43%
1-Month -1.49% -7.36% -0.51%
1-Year 23.33% -2.90% 62.22%
3-Year CAGR -1.16% -9.09% 18.26%
5-Year CAGR 15.92% 5.78% 19.85%

* Compound Annual Growth Rate

Here are more details on the Divis Laboratories share price and the Procter & Gamble Health share price.

Moving on to shareholding structures...

The promoters of Divis Laboratories hold a 51.9% stake in the company. In case of Procter & Gamble Health the stake stands at 51.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Divis Laboratories and the shareholding pattern of Procter & Gamble Health.

Finally, a word on dividends...

In the most recent financial year, Divis Laboratories paid a dividend of Rs 30.0 per share. This amounted to a Dividend Payout ratio of 43.7%.

Procter & Gamble Health paid Rs 95.0, and its dividend payout ratio stood at 68.7%.

You may visit here to review the dividend history of Divis Laboratories, and the dividend history of Procter & Gamble Health.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine(10:30 am)

Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.